Ashutosh Chilkoti
Fondatore presso Isolere Bio, Inc.
Profilo
Ashutosh Chilkoti founded PhaseBio Pharmaceuticals, Inc. in 2002, where he worked as Director from 2011 to 2018, Isolere Bio, Inc. in 2017, where he is working as Director from 2017, and inSoma Bio, Inc. in 2018, where he is working as Chairman.
Dr. Chilkoti also currently works at Duke University, as Professor.
Posizioni attive di Ashutosh Chilkoti
| Società | Posizione | Inizio |
|---|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
inSoma Bio, Inc.
 inSoma Bio, Inc. BiotechnologyHealth Technology inSoma Bio, Inc. operates as a biotechnology company. It engages in the creation of biomaterials to solve problems in tissue engineering and regenerative medicine. The company was founded by Stefan E. Roberts, Ashutosh Chilkoti, and Scott Hollenbeck in 2018 and is headquartered in Durham, NC. | Fondatore | 01/01/2018 |
Isolere Bio, Inc.
 Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Fondatore | 01/01/2017 |
Precedenti posizioni note di Ashutosh Chilkoti
| Società | Posizione | Fine |
|---|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Fondatore | 27/08/2018 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Isolere Bio, Inc.
Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Health Technology |
inSoma Bio, Inc.
inSoma Bio, Inc. BiotechnologyHealth Technology inSoma Bio, Inc. operates as a biotechnology company. It engages in the creation of biomaterials to solve problems in tissue engineering and regenerative medicine. The company was founded by Stefan E. Roberts, Ashutosh Chilkoti, and Scott Hollenbeck in 2018 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Ashutosh Chilkoti
